The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.
We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.
The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Félicitations aux chercheurs de @LDI_ILD, Marc Fabian et Stéphane Richard, qui s’associent à Darbix Biotech dans le cadre d’un projet financé par le CQDM visant à développer des thérapies anticancéreuses de nouvelle génération à base d’ARNm modifié
#CQDM
Congratulations to @LDI_ILD investigators Marc Fabian and Stéphane Richard, who are partnering with Darbix Biotech on a CQDM-funded project to develop next-generation modified mRNA cancer therapies
#RNAInnovation #CancerResearch #mRNA #QuebecResearch #CQDM
Congratulations to LDI investigators Guillaume Fontaine, Céline Gélinas and Brent Richards and to all the recipients!
Congratulations to LDI investigators Guillaume Fontaine, Céline Gélinas and Brent Richards and to all the recipients!
Nineteen Canada Research Chairs awarded to McGill 🔬
The newly appointed and renewed CRCs will drive forward research in fields that include critical care pain management, sustainable mining, linguistic justice, and so much more.
🔗 Learn more: https://mcgill.ca/x/5y4